VRTX insider filings

VERTEX PHARMACEUTICALS INC / MA — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen VRTX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 11 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
WAGNER CHARLES F JR — EVP, CO & FO1—1 leg · 15,286 sh · $8,374,741—
Kewalramani Reshma — CEO & President, Director1—1 leg · 11,866 sh · $6,307,135—
Thornberry Nancy — Director1—1 leg · 1,000 sh · $547,860—
Bhatia Sangeeta N. — Director1—1 leg · 271 sh · $148,470—
SACHS BRUCE I — Director2——2
Ambrose Kristen — SVP & Chief Accounting Officer1——1
Brennan Daniel J. — Director2——1
Garber Alan M — Director1——1
van Grunsven Jasper — EVP, CP and NPPO1——1

Recent insider filings — VERTEX PHARMACEUTICALS INC / MA

FiledFormInsiderReported transactionsSource
2026-11-184Bhatia Sangeeta N. — DirectorSale (S): 271 @ $547.86EDGAR
2026-11-184Thornberry Nancy — DirectorSale (S): 1,000 @ $547.86EDGAR
2026-11-164WAGNER CHARLES F JR — EVP, CO & FOSale (S): 15,286 @ $547.87EDGAR
2026-11-104Kewalramani Reshma — CEO & President, DirectorSale (S): 11,866 @ $531.53EDGAR
2026-10-224Brennan Daniel J. — DirectorGrant/award (A): 795 @ $503.47EDGAR
2026-10-223Brennan Daniel J. — DirectorHoldings only — no transactions reportedEDGAR
2026-10-194SACHS BRUCE I — DirectorGrant/award (A): 92.69 (derivative) @ $512.44EDGAR
2026-10-194Garber Alan M — DirectorGrant/award (A): 29.27 (derivative) @ $512.44EDGAR
2026-09-104van Grunsven Jasper — EVP, CP and NPPOGrant/award (A): 8,682 @ $0EDGAR
2026-09-014Ambrose Kristen — SVP & Chief Accounting OfficerGrant/award (A): 5,000 @ $0EDGAR
2026-08-314SACHS BRUCE I — DirectorGift (G): 6,000 @ $0EDGAR
2026-07-234Tatsis Ourania — EVP, Chief Reg. & Quality Off.Grant/award (A): 8,251 @ $0EDGAR
2026-07-234Sachdev Amit — EVP Chief Patient & Ext Af OffGrant/award (A): 8,251 @ $0EDGAR
2026-07-174Garber Alan M — DirectorGrant/award (A): 31.56 (derivative) @ $475.28EDGAR
2026-07-174SACHS BRUCE I — DirectorGrant/award (A): 99.94 (derivative) @ $475.28EDGAR
2026-07-074McKechnie Duncan — EVP, Chief Commercial OfficerSale (S): 1,541 @ $519EDGAR
2026-07-074Tatsis Ourania — EVP, Chief Reg. & Quality Off.Sale (S): 1,500 @ $524.99EDGAR
2026-07-064Liu Joy — EVP and Chief Legal OfficerSale (S): 828 @ $502.71EDGAR
2026-06-304Bozic Carmen — EVP and CMOSale (S): 596 @ $482.50EDGAR
2026-06-234Bozic Carmen — EVP and CMOSale (S): 1,020 @ $462.17EDGAR
2026-06-174Bozic Carmen — EVP and CMOSale (S): 4,062 @ $450EDGAR
2026-06-094Bozic Carmen — EVP and CMOSale (S): 1,745 @ $450EDGAR
2026-06-034Liu Joy — EVP and Chief Legal OfficerSale (S): 828 @ $439.91EDGAR
2026-06-024Bozic Carmen — EVP and CMOSale (S): 1,974 @ $450EDGAR
2026-05-194Bunnage Mark E. — EVP, Chief Scientific OfficerSale (S): 33 @ $453.45EDGAR
2026-05-194Bozic Carmen — EVP and CMOSale (S): 1,354 @ $453.45EDGAR
2026-05-144Bozic Carmen — EVP and CMOSale (S): 6,988 @ $450EDGAR
2026-05-054Liu Joy — EVP and Chief Legal OfficerSale (S): 1,104 @ $425.02EDGAR
2026-05-054Thornberry Nancy — DirectorGrant/award (A): 472 @ $0 · Disposition to issuer (D): 398 · Grant/award (A): 1,433 (derivative) @ $0 · Grant/award (A): 398 (derivative)EDGAR
2026-05-054Schneider Jennifer — DirectorGrant/award (A): 472 @ $0 · Disposition to issuer (D): 796 · Grant/award (A): 1,433 (derivative) @ $0 · Grant/award (A): 796 (derivative)EDGAR
2026-05-054MCKENZIE DIANA — DirectorGrant/award (A): 943 @ $0 · Disposition to issuer (D): 796 · Grant/award (A): 796 (derivative)EDGAR
2026-05-054Bhatia Sangeeta N. — DirectorGrant/award (A): 943 @ $0 · Sale (S): 318 @ $423.73EDGAR
2026-05-054Upadhyay Suketu — DirectorDisposition to issuer (D): 796 · Grant/award (A): 2,866 (derivative) @ $0 · Grant/award (A): 796 (derivative)EDGAR
2026-05-054Lagarde Michel — DirectorGrant/award (A): 2,866 (derivative) @ $0EDGAR
2026-05-054Garber Alan M — DirectorGrant/award (A): 472 @ $0 · Grant/award (A): 1,433 (derivative) @ $0EDGAR
2026-05-054CARNEY LLOYD — DirectorGrant/award (A): 2,866 (derivative) @ $0EDGAR
2026-05-054SACHS BRUCE I — DirectorGrant/award (A): 2,866 (derivative) @ $0EDGAR
2026-04-174Upadhyay Suketu — DirectorGrant/award (A): 80.51 (derivative) @ $442.50EDGAR
2026-04-174Garber Alan M — DirectorGrant/award (A): 33.90 (derivative) @ $442.50EDGAR
2026-04-174SACHS BRUCE I — DirectorGrant/award (A): 107.34 (derivative) @ $442.50EDGAR
2026-04-034Liu Joy — EVP and Chief Legal OfficerSale (S): 978 @ $449.17EDGAR
2026-03-314Bozic Carmen — EVP and CMOSale (S): 2,329 @ $450.95EDGAR
2026-03-174Bozic Carmen — EVP and CMOSale (S): 2,329 @ $481.79EDGAR
2026-03-134McKechnie Duncan — EVP, Chief Commercial OfficerSale (S): 2,633 @ $498.42EDGAR
2026-03-064McKechnie Duncan — EVP, Chief Commercial OfficerSale (S): 2,437 @ $475.30EDGAR
2026-03-044Liu Joy — EVP and Chief Legal OfficerSale (S): 892 @ $495.96EDGAR
2026-03-034Bozic Carmen — EVP and CMOSale (S): 2,329 @ $480.31EDGAR
2026-03-034Kewalramani Reshma — CEO & President, DirectorSale (S): 400 @ $479.75 · Sale (S): 120 @ $481.50 · Sale (S): 240 @ $482.84 · Sale (S): 2,510 @ $487.13 · Sale (S): 3,278 @ $488.27 · Sale (S): 460 @ $489.32 · +7 moreEDGAR
2026-03-024Ambrose Kristen — SVP & Chief Accounting OfficerSale (S): 357 @ $483.36EDGAR
2026-02-264WAGNER CHARLES F JR — EVP, CO & FOTax withholding (F): 1,744 @ $485.11EDGAR

Recent 8-K events — VERTEX PHARMACEUTICALS INC / MA

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-028-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-09-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-078-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
EDGAR
2026-05-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-298-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-318-K8.01 — Other EventsEDGAR
2026-02-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VRTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs